ConductScience.org, home

Paper974529

Enhanced HBsAb production in pathogenesis of fulminant viral hepatitis type B.

Woolf IL and 6 others. Br Med J, 1976. Cited by 88 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Enhanced HBsAb production in pathogenesis of fulminant viral hepatitis type B. Papers, record 974529. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/974529

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Enhanced HBsAb production in pathogenesis of fulminant viral hepatitis type B.
PubMed
Journal
Br Med J
PubMed
Year
1976
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
88
iCite
Relative citation ratio, by iCite
3.37
iCite
Revised in PubMed
2019-05-01
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Woolf ILI L
2El Sheikh NN
3Cullens HH
4Lee WMW M
5Eddleston ALA L
6Williams RR
7Zuckerman AJA J

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hepatitis BMajor topic
Hepatitis B Surface AntigensMajor topic
Acute Disease
Adolescent
Adult
Aged
Antibodies, Viral
Counterimmunoelectrophoresis
Female
Humans
Male
Microscopy, Electron
Middle Aged
Radioimmunoassay

Source PubMed

Download CSV of topics

References12

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
24132256Exposure and immunity to hepatitis-B virus in a liver unit.Lancet1974https://conductscience.org/library/papers/4132256PubMed
34250361Hepatitis-associated antigen.Am J Med1970https://conductscience.org/library/papers/4250361PubMed
44134346Prolonged survival in paraplegia due to metastatic spinal tumours.Lancet1974https://conductscience.org/library/papers/4134346PubMed
54703314Subtypes of Australia antigen among patients and healthy carriers in Copenhagen. A relation between the subtypes and the degree of liver damage in acute viral hepatitis.N Engl J Med1973https://conductscience.org/library/papers/4703314PubMed
65686429Viral hepatitis in Sydney: a review of fatal illnesses in a hospital series.Med J Aust1968https://conductscience.org/library/papers/5686429PubMed
71269974Hepatitis B antigen (HBSAg) and/or antibodies (anti-HBS and anti-HBC) in fulminant hepatitis: pathogenic and prognostic significance.Gut1976https://conductscience.org/library/papers/1269974PubMed
84111197Cellular immunity and hepatitis-associated, Australia antigen liver disease.Lancet1972https://conductscience.org/library/papers/4111197PubMed
94186979Immune complexes in hepatitis.Lancet1969https://conductscience.org/library/papers/4186979PubMed
104262014Sex distribution of Australia antigen.Arch Intern Med1972https://conductscience.org/library/papers/4262014PubMed
114568092Antibody responses in viral hepatitis, type B.JAMA1973https://conductscience.org/library/papers/4568092PubMed
1251345Fulminant hepatic failure in leukaemia and choriocarcinoma related to withdrawal of cytotoxic drug therapy.Lancet1975https://conductscience.org/library/papers/51345PubMed
134113680Long-incubation (virus B, HAA-associated) hepatitis.Gut1972https://conductscience.org/library/papers/4113680PubMed

Download CSV of references

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 88 citations.

PMIDTitleJournalYearIn PapersSource
30591937Bioinformatic identification of key genes and pathways that may be involved in the pathogenesis of HBV-associated acute liver failure.Genes Dis2018https://conductscience.org/library/papers/30591937PubMed
22198704Use of nucleoside (tide) analogues in patients with hepatitis B-related acute liver failure.Dig Dis Sci2012https://conductscience.org/library/papers/22198704PubMed
21987355Two distinct subtypes of hepatitis B virus-related acute liver failure are separable by quantitative serum immunoglobulin M anti-hepatitis B core antibody and hepatitis B virus DNA levels.Hepatology2012https://conductscience.org/library/papers/21987355PubMed
16741619Possible association of vigorous hepatitis B virus replication with the development of fulminant hepatitis.J Gastroenterol2006https://conductscience.org/library/papers/16741619PubMed
8784599Precore mutant of hepatitis B virus prevails in acute and chronic infections in an area in which hepatitis B is endemic.J Clin Microbiol1996https://conductscience.org/library/papers/8784599PubMed
7297915Circulating immune complexes in patients with fulminant hepatic failure.Gut1981https://conductscience.org/library/papers/7297915PubMed
7082040Clinically important immunological processes in acute and fulminant hepatitis, mainly due to hepatitis B virus.Arch Dis Child1982https://conductscience.org/library/papers/7082040PubMed
6980803Fulminant hepatic failure and artificial liver support.Gastroenterol Jpn1982https://conductscience.org/library/papers/6980803PubMed
6862285Hepatitis B virus DNA in children's liver diseases: detection by blot hybridisation in liver and serum.Gut1983https://conductscience.org/library/papers/6862285PubMed
6862284Serological markers in fulminant hepatitis B.Gut1983https://conductscience.org/library/papers/6862284PubMed
6767643Hepatitis type A, B, and non-A non-B in fulminant hepatitis.Gut1980https://conductscience.org/library/papers/6767643PubMed
6419891Multiplication of hepatitis B virus in fulminant hepatitis B.Br Med J (Clin Res Ed)1984https://conductscience.org/library/papers/6419891PubMed
3836964Fulminant hepatic failure in childhood.Indian J Pediatr1985https://conductscience.org/library/papers/3836964PubMed
3154194Treatment of a case of fulminant hepatic failure with continuous infusion of prostaglandin (PGE1).Korean J Intern Med1988https://conductscience.org/library/papers/3154194PubMed
2106465Anti-hepatitis C virus antibody prevails in fulminant hepatic failure.Gastroenterol Jpn1990https://conductscience.org/library/papers/2106465PubMed
1916470Viral hepatitis.Gut1991https://conductscience.org/library/papers/1916470PubMed
1909270Detection of anti-hepatitis C virus antibody in fulminant hepatic failure.Gastroenterol Jpn1991https://conductscience.org/library/papers/1909270PubMed
1695027Fulminant hepatitis.Springer Semin Immunopathol1990https://conductscience.org/library/papers/1695027PubMed
1326465Estimation of IgG subclasses of anti-HCV (C100-3) in non-A, non-B fulminant, acute and chronic hepatitis and it's significance.Gastroenterol Jpn1992https://conductscience.org/library/papers/1326465PubMed
437551Changes in hepatitis B virus DNA polymerase in relation to the outcome of acute hepatitis type B.Gut1979https://conductscience.org/library/papers/437551PubMed

See all 21 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/974529

GET https://conductscience.org/api/papers/v1/974529/cited_by?page=2